Dermapharm Holding SE (DMP) — Net Asset Quality Index
Dermapharm Holding SE (DMP) has a Net Asset Quality Index of 32.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €2.27 Billion minus total liabilities of €1.54 Billion yields net assets of €735.17 Million. A higher index indicates a stronger, lower-leverage balance sheet. See operational self-sufficiency of Dermapharm Holding SE to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Dermapharm Holding SE Net Asset Quality Index Over Time (2013–2025)
This chart shows how Dermapharm Holding SE's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 32.3%, representing net assets of €735.17 Million against total assets of €2.27 Billion EUR. Explore Dermapharm Holding SE (DMP) cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Dermapharm Holding SE (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Dermapharm Holding SE from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Dermapharm Holding SE stock valuation.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 31.8% | €701.83 Million | €2.20 Billion | €1.50 Billion | ▲ +2.6 pp |
| 2024 | 29.2% | €608.29 Million | €2.08 Billion | €1.47 Billion | ▲ +4.0 pp |
| 2023 | 25.2% | €545.05 Million | €2.16 Billion | €1.62 Billion | ▼ -12.5 pp |
| 2022 | 37.7% | €532.49 Million | €1.41 Billion | €880.34 Million | ▲ +2.2 pp |
| 2021 | 35.5% | €499.83 Million | €1.41 Billion | €907.13 Million | ▲ +9.0 pp |
| 2020 | 26.5% | €324.58 Million | €1.22 Billion | €899.81 Million | ▼ -0.7 pp |
| 2019 | 27.2% | €284.49 Million | €1.04 Billion | €760.38 Million | ▼ -9.1 pp |
| 2018 | 36.3% | €256.08 Million | €704.58 Million | €448.50 Million | ▲ +18.6 pp |
| 2017 | 17.7% | €73.69 Million | €415.30 Million | €341.62 Million | ▼ -1.8 pp |
| 2016 | 19.5% | €60.81 Million | €311.70 Million | €250.89 Million | ▲ +4.5 pp |
| 2015 | 15.0% | €44.44 Million | €296.67 Million | €252.22 Million | ▲ +4.7 pp |
| 2014 | 10.3% | €34.01 Million | €330.60 Million | €296.59 Million | ▼ -1.5 pp |
| 2013 | 11.8% | €41.36 Million | €349.98 Million | €308.62 Million | — |